ClearOne, Inc. Reports Third Quarter 2024 Financial Results
-Sequential Revenue increase points to recovery from prior year impacts-
-Sequential and Year-over-Year OpEx Reductions Reflect Continued Benefits of Cost Optimization Initiatives-
Revenue decreased 42% year over year, primarily due to a significant decrease in revenues from the audio conferencing category, which includes our DSP mixer products. “We believe this revenue decline was primarily due to the cumulative impact of past production shortages,” said
Operational Highlights
- The Company generated a sequential revenue increase of 8.7% from Q2 2024 to Q3 2024.
- The Company reduced operating expenses by 10.1% sequentially and 9.33% year-over-year.
- The ClearOne BMA 360 beamforming microphone array was announced as the winner of the Utah Innovation Awards in the Consumer Product Category by Utah Business. Utah Business noted the BMA 360's unique combination of hardware microphone layout, microphone sensor capability and optimization algorithm.
- The DIALOG® UVHF wireless Microphone system was named a winner of the 2024 Communications Solutions products of the year award.
- We recorded a 31% increase in unique visitors at our 2024 Infocomm India trade show booth, while the overall annual increase of all attendees at that trade show was only 17%.
Graham continued, “Throughout 2024, our team has been diligently working to win back customers who have defected to competing brands. We believe the sequential increase in revenue we saw in Q3 indicates that this work is beginning to bear fruit.”
Financial Summary
The Company uses certain non-GAAP financial measures and reconciles those to GAAP measures in the attached tables.
-
Q3 2024 revenue was
$2.5 million , compared to$4.9 million in Q3 2023 and$2.3 million in Q2 2024. We believe the revenue decrease year over year was mainly due to sustained inventory sourcing and order fulfillment challenges for the Company's core audio conferencing and beam forming microphone arrays as a result of delays in the transition of outsourced manufacturing fromChina toSingapore throughout 2023. The 8.7% sequential increase was driven by increased demand across all product categories. We believe the flow of sales orders during Q3 2024 increased due to the start of recovery from the cumulative impact of past product shortages. -
GAAP gross profit/loss in Q3 2024 was
$0.6 million , compared to$1.6 million in Q3 2023 and$(0.02) million in Q2 2024. GAAP gross profit margin was 24% in Q3 2024, compared to (1)% in Q2 2024 and 33% in Q3 2023. The large decrease in gross profit margin year over year occurred due to increased inventory scrap costs, and an increase in purchase price variance from increasing vendor costs. -
Operating expenses in Q3 2024 improved to
$2.8 million , compared to$3.1 million in Q3 2023 and$2.9 million in Q2 2024. Non-GAAP operating expenses in Q3 2024 improved to$2.7 million compared to$2.8 million in Q2 2024 and$2.9 million in Q3 2023. The sequential and year-over-year decrease in non-GAAP operating expenses was mainly due to the continued benefits of the cost-cutting measures initiated in 2022. -
GAAP net loss in Q3 2024 was
$(2.1) million , or$(0.09) per share, compared to a net loss of$(1.4) million , or$(0.06) per share, in Q3 2023 and a net loss of$(2.8) million , or$(0.12) per share, in Q2 2024. The year-over-year increase in net loss was primarily due to the aforementioned decrease in revenue and gross profit, partially offset by a decrease in operating expenses. -
Non-GAAP net loss in Q3 2024 was
$(2.0) million , or$(0.08) per share, compared to a Non-GAAP net loss of$(1.2) million , or$(0.05) per share, in Q3 2023 and a Non-GAAP net loss of$(2.7) million , or$(0.11) per share, in Q2 2024. The year-over-year increase in Non-GAAP net loss was driven by the aforementioned decrease in revenue and gross profit partially offset by a decrease in operating expenses.
($ in 000, except per share) |
Three months ended |
|
Nine months ended |
|||||||||||||||||||
|
2024 |
|
2023 |
|
Change in % Favorable/(Adverse) |
|
2024 |
|
2023 |
|
Change in % Favorable/(Adverse) |
|||||||||||
GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
$ |
2,504 |
|
|
$ |
4,889 |
|
|
(49 |
) |
|
$ |
8,430 |
|
|
$ |
14,550 |
|
|
(42 |
) |
|
Gross profit |
|
612 |
|
|
1,616 |
|
|
(62 |
) |
|
|
1,743 |
|
|
|
4,779 |
|
|
(64 |
) |
||
Operating expenses |
|
2,800 |
|
|
|
3,105 |
|
|
10 |
|
|
|
8,933 |
|
|
|
9,812 |
|
|
9 |
|
|
Operating loss |
|
(2,188 |
) |
|
|
(1,489 |
) |
|
(47 |
) |
|
|
(7,190 |
) |
|
|
(5,033 |
) |
|
(43 |
) |
|
Net loss |
|
(2,062 |
) |
|
|
(1,351 |
) |
|
(53 |
) |
|
|
(6,780 |
) |
|
|
(3,202 |
) |
|
(112 |
) |
|
Diluted loss per share |
|
(0.09 |
) |
|
|
(0.06 |
) |
|
(50 |
) |
|
|
(0.28 |
) |
|
|
(0.13 |
) |
|
(115 |
) |
|
Non-GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP operating expenses |
$ |
2,738 |
|
$ |
2,933 |
|
|
7 |
|
$ |
8,670 |
|
$ |
9,349 |
|
|
7 |
|
||||
Non-GAAP operating loss |
|
(2,118 |
) |
|
|
(1,315 |
) |
|
(61 |
) |
|
|
(6,908 |
) |
|
|
(4,565 |
) |
|
(51 |
) |
|
Non-GAAP net loss |
|
(1,992 |
) |
|
|
(1,177 |
) |
|
(69 |
) |
|
|
(6,498 |
) |
|
|
(4,084 |
) |
|
(59 |
) |
|
Non-GAAP Adjusted EBITDA |
|
(1,982 |
) |
|
|
(1,006 |
) |
|
(97 |
) |
|
|
(6,597 |
) |
|
|
(3,395 |
) |
|
(94 |
) |
|
Non-GAAP diluted loss per share |
|
(0.08 |
) |
|
|
(0.05 |
) |
|
(60 |
) |
|
|
(0.27 |
) |
|
|
(0.17 |
) |
|
(59 |
) |
Balance Sheet Highlights
As of
About
Non-GAAP Financial Measures
To supplement our consolidated financial statements presented on a GAAP basis,
Forward Looking Statements
This release contains “forward-looking” statements that are based on present circumstances and on ClearOne’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements and any statements of the plans and objectives of management for future operations and forecasts of future growth and value are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. Such forward-looking statements are made only as of the date of this release and
In particular, the financial information contained herein is subject to and qualified by reference to the financial statements contained in the 10-Q, including the footnotes thereto, as well as the Company’s annual report on Form 10-K for the year ended
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Dollars in thousands, except par value) |
||||||||
|
|
|
|
|
||||
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
1,685 |
|
|
$ |
17,835 |
|
Current marketable securities |
|
|
1,136 |
|
|
|
3,480 |
|
Patent cross license receivable |
|
|
— |
|
|
|
4,000 |
|
Receivables, net of allowance of |
|
|
1,868 |
|
|
|
3,279 |
|
Inventories, net |
|
|
14,269 |
|
|
|
10,625 |
|
Income tax receivable |
|
|
27 |
|
|
|
36 |
|
Prepaid expenses and other assets |
|
|
4,054 |
|
|
|
4,062 |
|
Total current assets |
|
|
23,039 |
|
|
|
43,317 |
|
Long-term marketable securities |
|
|
222 |
|
|
|
916 |
|
Long-term inventories, net |
|
|
2,237 |
|
|
|
3,143 |
|
Property and equipment, net |
|
|
518 |
|
|
|
530 |
|
Operating lease - right of use assets, net |
|
|
718 |
|
|
|
990 |
|
Intangibles, net |
|
|
1,567 |
|
|
|
1,689 |
|
Other assets |
|
|
78 |
|
|
|
109 |
|
Total assets |
|
$ |
28,379 |
|
|
$ |
50,694 |
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
1,248 |
|
|
$ |
1,945 |
|
Accrued liabilities |
|
|
2,057 |
|
|
|
2,290 |
|
Deferred product revenue |
|
|
22 |
|
|
|
30 |
|
Total current liabilities |
|
|
3,327 |
|
|
|
4,265 |
|
Operating lease liability, net of current |
|
|
472 |
|
|
|
665 |
|
Other long-term liabilities |
|
|
1,079 |
|
|
|
1,079 |
|
Total liabilities |
|
|
4,878 |
|
|
|
6,009 |
|
|
|
|
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
|
|
|
|
Common stock, par value |
|
|
24 |
|
|
|
24 |
|
Additional paid-in capital |
|
|
31,640 |
|
|
|
46,047 |
|
Accumulated other comprehensive loss |
|
|
(307 |
) |
|
|
(310 |
) |
Accumulated deficit |
|
|
(7,856 |
) |
|
|
(1,076 |
) |
Total shareholders' equity |
|
|
23,501 |
|
|
|
44,685 |
|
Total liabilities and shareholders' equity |
|
$ |
28,379 |
|
|
$ |
50,694 |
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Dollars in thousands, except per share amounts) |
||||||||||||||||
|
|
Three months ended |
|
Nine months ended |
||||||||||||
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||
Revenue |
|
$ |
2,504 |
|
|
$ |
4,889 |
|
|
$ |
8,430 |
|
|
$ |
14,550 |
|
Cost of goods sold |
|
|
1,892 |
|
|
|
3,273 |
|
|
|
6,687 |
|
|
|
9,771 |
|
Gross profit |
|
|
612 |
|
|
1,616 |
|
|
|
1,743 |
|
|
|
4,779 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
1,067 |
|
|
|
1,119 |
|
|
|
3,570 |
|
|
|
3,634 |
|
Research and product development |
|
|
782 |
|
|
|
889 |
|
|
|
2,544 |
|
|
|
2,805 |
|
General and administrative |
|
|
951 |
|
|
|
1,097 |
|
|
|
2,819 |
|
|
|
3,373 |
|
Total operating expenses |
|
|
2,800 |
|
|
|
3,105 |
|
|
|
8,933 |
|
|
|
9,812 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
|
(2,188 |
) |
|
|
(1,489 |
) |
|
|
(7,190 |
) |
|
|
(5,033 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
29 |
|
|
(86 |
) |
|
|
264 |
|
|
|
(469 |
) |
|
Other income, net |
|
|
113 |
|
|
|
243 |
|
|
175 |
|
|
|
2,346 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes |
|
|
(2,046 |
) |
|
|
(1,332 |
) |
|
|
(6,751 |
) |
|
|
(3,156 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes |
|
|
16 |
|
|
19 |
|
|
|
29 |
|
|
|
46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(2,062 |
) |
|
$ |
(1,351 |
) |
|
$ |
(6,780 |
) |
|
$ |
(3,202 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average shares outstanding |
|
|
23,969,148 |
|
|
|
23,960,313 |
|
|
|
23,969,148 |
|
|
|
23,957,311 |
|
Diluted weighted average shares outstanding |
|
|
23,969,148 |
|
|
|
23,960,313 |
|
|
|
23,969,148 |
|
|
|
23,957,311 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic loss per share |
|
$ |
(0.09 |
) |
|
$ |
(0.06 |
) |
|
$ |
(0.28 |
) |
|
$ |
(0.13 |
) |
Diluted loss per share |
|
$ |
(0.09 |
) |
|
$ |
(0.06 |
) |
|
$ |
(0.28 |
) |
|
$ |
(0.13 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(2,062 |
) |
|
$ |
(1,351 |
) |
|
$ |
(6,780 |
) |
|
$ |
(3,202 |
) |
Unrealized loss on available-for-sale securities, net of tax |
|
|
(1 |
) |
|
|
(31 |
) |
|
|
18 |
|
|
|
(17 |
) |
Change in foreign currency translation adjustment |
|
|
(12 |
) |
|
|
(7 |
) |
|
|
(15 |
) |
|
|
(3 |
) |
Comprehensive loss |
|
$ |
(2,075 |
) |
|
$ |
(1,389 |
) |
|
$ |
(6,777 |
) |
|
$ |
(3,222 |
) |
UNAUDITED RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES (Dollars in thousands, except per share values) |
||||||||||||||||
|
|
Three months ended |
|
Nine months ended |
||||||||||||
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||
GAAP operating loss |
|
$ |
(2,188 |
) |
|
$ |
(1,489 |
) |
|
$ |
(7,190 |
) |
|
$ |
(5,033 |
) |
Stock-based compensation |
|
|
21 |
|
|
|
33 |
|
|
|
73 |
|
|
|
80 |
|
Amortization of intangibles |
|
|
49 |
|
|
|
141 |
|
|
|
209 |
|
|
|
388 |
|
Non-GAAP operating loss |
|
$ |
(2,118 |
) |
|
$ |
(1,315 |
) |
|
$ |
(6,908 |
) |
|
$ |
(4,565 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
$ |
(2,062 |
) |
|
$ |
(1,351 |
) |
|
|
(6,780 |
) |
|
|
(3,202 |
) |
Stock-based compensation |
|
|
21 |
|
|
|
33 |
|
|
|
73 |
|
|
|
80 |
|
Amortization of intangibles |
|
|
49 |
|
|
|
141 |
|
|
|
209 |
|
|
|
388 |
|
Other income adjustment |
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
(1,350 |
) |
|
Non-GAAP net loss |
|
$ |
(1,992 |
) |
|
$ |
(1,177 |
) |
|
$ |
(6,498 |
) |
|
$ |
(4,084 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
$ |
(2,062 |
) |
|
$ |
(1,351 |
) |
|
$ |
(6,780 |
) |
|
$ |
(3,202 |
) |
Number of shares used in computing GAAP diluted loss per share |
|
|
23,969,148 |
|
|
|
23,960,313 |
|
|
|
23,969,148 |
|
|
|
23,957,311 |
|
GAAP diluted loss per share |
|
$ |
(0.09 |
) |
|
$ |
(0.06 |
) |
|
$ |
(0.28 |
) |
|
$ |
(0.13 |
) |
Non-GAAP net loss |
|
$ |
(1,992 |
) |
|
$ |
(1,177 |
) |
|
$ |
(6,498 |
) |
|
$ |
(4,084 |
) |
Number of shares used in computing Non-GAAP diluted loss per share |
|
|
23,969,148 |
|
|
|
23,960,313 |
|
|
|
23,969,148 |
|
|
|
23,957,311 |
|
Non-GAAP diluted loss per share |
|
$ |
(0.08 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.27 |
) |
|
$ |
(0.17 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
$ |
(2,062 |
) |
|
$ |
(1,351 |
) |
|
$ |
(6,780 |
) |
|
$ |
(3,202 |
) |
Stock-based compensation |
|
|
21 |
|
|
|
33 |
|
|
|
73 |
|
|
|
80 |
|
Interest expense |
|
|
(29 |
) |
|
|
86 |
|
|
|
(264 |
) |
|
|
469 |
|
Depreciation |
|
|
110 |
|
|
|
66 |
|
|
|
223 |
|
|
|
174 |
|
Amortization of intangibles |
|
|
49 |
|
|
|
141 |
|
|
|
209 |
|
|
|
388 |
|
Other income adjustment |
|
|
(87 |
) |
|
|
— |
|
|
(87 |
) |
|
|
(1,350 |
) |
|
Provision for income taxes |
|
|
16 |
|
|
19 |
|
|
|
29 |
|
|
|
46 |
|
|
Non-GAAP Adjusted EBITDA |
|
$ |
(1,982 |
) |
|
$ |
(1,006 |
) |
|
$ |
(6,597 |
) |
|
$ |
(3,395 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20241115081723/en/
Investor Relations Contact:
385-426-0565
investor_relations@clearone.com
http://investors.clearone.com
Source: